ArticleCureus2025
A New Generation of Porphyrias: A Case of Acute Intermittent Porphyria.
Article in Cureus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Porphyria refers to metabolic disorders caused by dysfunctional heme biosynthesis. Acute intermittent porphyria (AIP) is the most common and severe form of acute porphyria, inherited in an autosomal dominant pattern. During a crisis, diagnosis can be established by collecting urine, plasma, and stool samples for work-up, and treatment should be started. We report the case of a 41-year-old female patient with a known history of AIP and prior recurrent crises, presenting with severe intracranial hemorrhage due to aneurysm rupture secondary to a hypertensive emergency at the age of 38. She presented to the Emergency Department with nausea, vomiting, abdominal and lower limb pain, left upper and lower limb paresthesias, anxiety, and insomnia. A positive Hoesch test led to a presumptive diagnosis of AIP crisis. Fecal and urinary laboratory work-ups were compatible with an AIP crisis. Genetic studies for new generation porphyrias identified a heterozygous variant p.Leu42Ser in the hydroxymethylbilane synthase (HMBS) gene, probably a pathogenic variant. She completed four days of treatment with hematin, with complete resolution of pain. We highlight the need for prompt evaluation and diagnosis of an AIP crisis, particularly in patients with a known personal or family history of AIP. New therapeutic alternatives with minor side effects are now available and should be started as soon as possible. Given that symptoms are often nonspecific and variable, there should be a high index of suspicion in these patients.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.